Form 4 for NVCR NovoCure Ltd
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-28 · accession 0001917165-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-28 | NVCR | Ben Arye Barak | GC | A - Grant | $0.00 | +17.8K | 192.3K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-28 | A | A | 17,755 | $0.00 | 192,328 | D | — | — | (F1) Represents vesting of performance-based restricted stock units. |